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Molecular structure of human CFTR
determined in the dephosphorylated,
ATP-free conformation provides insights
on the structural basis for its channel
activity.
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The cystic fibrosis transmembrane conductance
regulator (CFTR) is an ATP-binding cassette (ABC)
transporter that uniquely functions as an ion channel.
Here, we present a 3.9 A˚ structure of dephosphory-
lated human CFTR without nucleotides, determined
by electron cryomicroscopy (cryo-EM). Close resem-
blance of this human CFTR structure to zebrafish
CFTR under identical conditions reinforces its rele-
vance for understanding CFTR function. The human
CFTR structure reveals a previously unresolved helix
belonging to the R domain docked inside the intra-
cellular vestibule, precluding channel opening. By
analyzing the sigmoid time course of CFTR current
activation, we propose that PKA phosphorylation of
the R domain is enabled by its infrequent sponta-
neous disengagement, which also explains residual
ATPase and gating activity of dephosphorylated
CFTR. From comparison with MRP1, a feature distin-
guishing CFTR from all other ABC transporters is the
helix-loop transition in transmembrane helix 8, which
likely forms the structural basis for CFTR’s channel
function.INTRODUCTION
Cystic fibrosis (CF) is themost common lethal genetic disorder in
populations of Northern European descent, affecting one out of
every 2,500 newborns (Boat et al., 1989; Rommens et al., 1989).
It is caused by mutations in a single gene, the cystic fibrosis
transmembrane conductance regulator (CFTR) (Riordan et al.,
1989; Rommens et al., 1989). CFTR belongs to the ATP-binding
cassette (ABC) superfamily, but it is unique among ABC proteins
in that it functions as an ion channel (Gadsby et al., 2006).
Whereas other ABC transporters utilize the chemical energy of
ATP hydrolysis to transport substrates against their chemical
gradients, CFTR conducts anions down their electrochemical
gradient.
A typical ABC transporter consists of two transmembrane do-
mains (TMDs) that form the translocation pathway and two cyto-plasmic nucleotide-binding domains (NBDs) that hydrolyze ATP.
CFTR contains an additional regulatory (R) domain that must be
phosphorylated to allow the channel to open (Cheng et al., 1991).
Once the R domain is phosphorylated, ATP binding opens the
CFTR channel and ATP hydrolysis closes it (Gunderson and Ko-
pito, 1995). The molecular mechanisms underlying R domain
regulation and ATP-dependent gating have been studied for
many years, but several key questions remain unanswered.
Recently, we determined the structure of CFTR from zebrafish
(Zhang and Chen, 2016). We showed that the ion conduction
pathway consists of a large cytosolic vestibule, a narrow trans-
membrane (TM) tunnel, and a single gate near the extracellular
surface. The dephosphorylated regulatory domain, found in the
intracellular opening between the two cytosolic halves of the
molecule, is positioned to prevent NBD dimerization. However,
because only 55% of zebrafish and human CFTR sequence is
identical, and because most functional studies were of human
CFTR, we reasoned that the structure of human CFTR is essen-
tial to directly correlate structure with function.RESULTS AND DISCUSSION
Structural Determination
Full-length human CFTR was overexpressed and purified from
human embryonic kidney cells and treated with phosphatase to
obtain a homogeneous sample of dephosphorylated protein.
Electron cryomicroscopy (cryo-EM) reconstruction was carried
out in the absence of nucleotides to an overall resolution of
3.9 A˚ (Figure S1). The local resolution, estimated by Blocres
from the Bsoft package (Heymann and Belnap, 2007), varies
from 2.4 A˚ to 6.0 A˚ (Figure S1). We built all of the transmem-
brane helices de novo as the map shows well-defined densities
for most of the side chains (Figure S2). High-resolution crystal
structures of isolated NBDs were docked into the cryo-EM
map and side-chain positions were manually adjusted based
on the EM density (Figure S2). A tubular density was clearly
visible between the two halves of the molecule; but it lacks
side-chain features to establish the amino acid register (Figures
S2 and S3). We modeled a short helix likely corresponding to
the C-proximal end of the R domain into this density. The final
structure, which contains nearly complete atomic models for
the lasso, TMD1, TMD2, NBD1, NBD2, and a polyalanine model
of residues 825–843, was refined against the EM maps to goodCell 169, 85–95, March 23, 2017 ª 2017 Elsevier Inc. 85
Figure 1. The Overall Structure of Human CFTR in the Dephosphorylated, ATP-Free Conformation
(A) The domain structure of CFTR.
(B) Ribbon diagram of two views. The EM densities shown in red correspond to unstructured regions within the R insertion of NBD1 or the R domain. Regions
not resolved in the structure are shown as dashed lines for visualization purposes only, they are not meant to imply connectivity or the location of the missing
regions.
See also Figures S1–S3 and Table S1.statistics and excellent stereochemistry (Figures 1 and S1;
Table S1).
In this non-phosphorylated, closed-channel conformation,
CFTR resembles a typical ABC transporter in its inward-facing
conformation (Figure 1). The 12 TM helices in the TMDs pack
tightly in themembraneouter leaflet. In the inner leaflet, the helices
segregate into two bundles extending 30 A˚ into the cytoplasm.
The two NBDs, each attached to a cytosolic TM helical bundle,
are well separated. The R domain, mostly unstructured, inserts
between the cytoplasmic extension of the TMDs and packs along
NBD1 in the opening between the two halves of the molecule.
Structural Comparison of the Two CFTR Orthologs
This structure of human CFTR is very similar to that of the de-
phosphorylated zebrafish ortholog, evident by the overall root-
mean-square deviation (RMSD) of 1.9 A˚ for 1,062 Ca positions
(Figure 2A). Several prominent features of CFTR, including the
N-terminal interfacial lasso motif (Figure 2B), the discontinuity
of helix TM8 (Figure 2C), and the asymmetric opening of the
NBDs (Figure 2D), are conserved in both human and zebrafish
orthologs. The positions of functionally important residues,
such as the R347/D924 (TM6/TM8) salt-bridge (Figure 2E), the
TM6 gating residues F337 and T338 (Figure 2E), and many
pore-lining residues (Figure 3) are very similar in both structures.
These structural similarities between human and zebrafish
CFTR, given that they possess only 55% sequence identity,
have significance. Our observation of closely similar structures86 Cell 169, 85–95, March 23, 2017in CFTR from two different species offers confidence that both
cryo-EM structures represent a functionally informative confor-
mation. Thus, major conclusions reached on the basis of the
zebrafish ortholog (Zhang and Chen, 2016), including the con-
struction of the ion-conduction pathway, the separation of the
NBDs, the positioning of the R domain, and the structural inter-
pretation of many cystic fibrosis-causing mutations, are now
reinforced by the human CFTR structure.
It is quite remarkable that the distances between the two
NBDs are so similar in zebrafish and human CFTR (Figure 2D).
Many ABC transporters appear to be very flexible in the
inward-facing conformation. For example, several crystal struc-
tures of the mouse P-glycoprotein display a distribution of
distances separating the two NBDs (Ward et al., 2013). Similarly,
EM studies of MsbA and P-glycoprotein revealed numerous
conformations of both transporters (Frank et al., 2016; Moeller
et al., 2015). In stark contrast, we find practically identical confor-
mations and NBD separations in two structures of CFTR from
different species, suggesting that the conformational flexibility
observed in other ABC transporters is substantially diminished
in CFTR.We propose this is due to the presence of the R domain,
which in its unphosphorylated state is seen to contact both
halves of the molecule (Figure 1).
Functional Role of Positively Charged Residues
Integral membrane proteins in general contain predominantly
hydrophobic residues that form transmembrane segments.
Figure 2. Structural Comparison of Human and Zebrafish CFTR
(A) Superposition of the overall structures. Human CFTR is shown in blue, and zebrafish CFTR is in yellow.
(B) Superposition of the lasso motif.
(C) The TM helix 7 in zebrafish CFTR is ten residues longer than that of human CFTR. The residue numbers of human (blue) and zebrafish (yellow) CFTR are
indicated.
(D) The asymmetric opening of the NBD interface is conserved in both human and zebrafish CFTR. The distances between the Ca atoms of the conserved glycine
in the Walker A motif and the serine in the signature motif are indicated.
(E) Superposition showing the locations of several functionally well-characterized residues.Positively charged arginine and lysine residues are often found at
the cytoplasmic boundaries of the membrane proteins, but are
rare within the membrane core or near the extracellular surface.This biased distribution of positively charged residues, the
‘‘positive-inside’’ rule, is important in directing the topology of
membrane proteins (Heijne, 1986; Nilsson et al., 2005). CFTR,Cell 169, 85–95, March 23, 2017 87
Figure 3. Stereo Viewof the Ion-Conduction
Pathway
The pore is shown as a gray mesh. Positively
charged residues involved in recruiting extracel-
lular ions are shown in pink, including R104,
R117, R334, and K335 (Gong and Linsdell, 2003;
Smith et al., 2001; Zhou et al., 2008). Other resi-
dues involved in ion conductance are shown in
magenta, including K95, K190, R248, R303, R352,
K370, K1041, and R1048 (Aubin and Linsdell,
2006; El Hiani and Linsdell, 2015; Ge et al., 2004;
Zhou et al., 2007, 2008). Positively charged resi-
dues not involved in ion conduction are shown in
yellow, including R80, K114, R242, R251, K254,
K294, R297, K298, K329, R933, K946, R975,
R1030, R1102, R1128, R1162, and R1165 (Aubin
and Linsdell, 2006; El Hiani and Linsdell, 2015;
Zhang and Hwang, 2015; Zhou et al., 2008).however, contains a large number of arginines and lysines
distributed throughout the TMDs. The functional roles of individ-
ual arginine and lysine residues have been studied extensively
(Linsdell, 2017). Single amino acid substitution of K95, R104,
R117, K190, R248, R303, R334, K335, R352, K370, K1041,
and R1048 decreases the single-channel conductance in a
charge-dependent manner, suggesting that they play a role in at-
tracting anions into the pore through electrostatic interactions
(Aubin and Linsdell, 2006; El Hiani and Linsdell, 2015; Ge et al.,
2004; Smith et al., 2001; Zhou et al., 2007, 2008, 2010). Of these
residues, R104, R117, R334, and K335 are located in the extra-
cellular region (Figure 3, pink residues). Removing these positive
charges leads to inward rectification, consistent with their role in
recruiting extracellular anions (Gong and Linsdell, 2003; Smith
et al., 2001; Zhou et al., 2008). All other functionally important
arginines and lysines are located on the surface of the ion con-
duction pathway (Figure 3, magenta residues). The side chains
of these residues, not engaged in any specific interactions with
other parts of the protein in the closed channel, are available
to bind anions. In contrast, numerous positively charged resi-
dues do not affect anion permeation, including R80, K114,
R242, R251, K254, K294, R297, K298, K329, R933, K946,
R975, R1030, R1102, R1128, R1162, and R1165 (Aubin and
Linsdell, 2006; El Hiani and Linsdell, 2015; Zhang and Hwang,
2015; Zhou et al., 2008); all of these residues are located far
from the pore (Figure 3, yellow residues).
Do these positively charged residues contribute to ion selec-
tivity? CFTR is a relatively non-selective anion channel, permit-
ting permeation of many monovalent anions including thiocya-
nate, nitrate, bromide, chloride, iodide, fluoride, formate, and
bicarbonate (Linsdell, 2017). Mutagenesis studies have not
identified any particular residue involved in determining the
observed lyotropic anion selectivity sequence (Linsdell, 2017).
Therefore, it is likely that the selection of anions over cations
in CFTR comes from the overall positive charge of the pore
(Zhang and Chen, 2016) rather than individual residues or a nar-
row selectivity filter as seen in K channels (Doyle et al., 1998).
Large divalent anions, such as phosphates and sulfates, are
not conducted by CFTR. Whether this is due to a narrow region88 Cell 169, 85–95, March 23, 2017of the ion pathway must await the structure of an open CFTR
channel.
Unphosphorylated R Domain Prevents NBD
Dimerization
It has been established that opening of a CFTR channel is
strictly coupled to the formation of a closed NBD dimer (Miha´lyi
et al., 2016; Vergani et al., 2005). The location of the unphos-
phorylated R domain observed in both human (Figure 1) and ze-
brafish CFTR structures (Zhang and Chen, 2016) is consistent
with its inhibitory role (Csana´dy et al., 2000) by preventing
NBD dimerization and thereby channel opening (Zhang and
Chen, 2016). In human CFTR, we also resolve an additional he-
lical structure wedged into the intracellular space between the
two halves of the molecule, interacting with TM helices 9, 10,
and 12 (Figure 4A). Because the density of this region is posi-
tioned so as to connect to the elbow helix in TMD2 (Figure S3),
it most likely corresponds to residues 825–843 of the R domain
(R825–843).
Although there is no phosphorylation site within residues 825–
843, the overall charge of this region is very negative: it contains
seven aspartate and glutamate residues, which account for 37%
of its amino acid composition. Many polar residues in TMD2 are
in van der Waals’s contact with R825–843 (Figure 4A). Among
these potential interacting residues, substitutions of K978 with
cysteine, serine, or proline were shown to increase CFTR chan-
nel activity independent of ATP (Wang et al., 2010). It would
seem possible that removing the positive charge at position
978 lowers the affinity for R825–843, thus facilitating R domain
release from its inhibitory position.
To further illustrate the fact that R825–843 must relocate to
allow the channel to open, we compared the local structure
of CFTR with that of Sav1866, a nucleotide-bound ABC
exporter in the outward-facing conformation (Dawson and
Locher, 2007). As shown in Figure 4B, the intracellular cavity
between the two helical bundles narrows upon NBD dimeriza-
tion. This narrowing would be incompatible with the helical
R825–843 inserted as observed in the closed CFTR channel
structure.
Figure 4. The Dephosphorylated R Domain Inhibits Channel Opening
(A) Residues 825–843 of the R domain (shown in red) insert into an opening between TM9 and TM10. Also shown in a close-up view are residues in van der Waals’
contact with R825–843, including K978.
(B) Structure of Sav1866 (PDB: 2ONJ) showing that helices corresponding to CFTR TM9 and TM10 are in close contact upon NBD dimerization.
See also Figure S3.Channel Activation by R Domain Phosphorylation
Easy access of PKA catalytic subunit (30 kDa) to the R do-
main’s multiple PKA consensus-site serines (Table S2) during
channel activation by phosphorylation likely also requires the
R domain to first be released from between the NBDs and
TM extensions. Support for this comes from the sigmoid time
course of current activation on sudden addition of a maximally
activating concentration of PKA to membrane patches contain-
ing hundreds of human CFTR channels (Figure 5A). Fits of such
current activations (in 11 patches) to a two-step process (e.g.,
like that in Figure 5B) yielded a slower (mean ka1 = 0.07 ±
0.01 s1) and a faster (mean ka2 = 0.26 ± 0.05 s
1) rate for
the two sequential activation steps. In contrast, application of
a maximal PKA concentration to channels that are already
partially activated increased current along an exponential
time course, at a rate similar to that of the faster step, ka2 (Csa-
na´dy et al., 2005b). We therefore interpret the slower of the
sequential steps to reflect infrequent spontaneous disengage-
ment and release of the R domain and the faster step to reflect
subsequent rapid phosphorylation of the R domain once
released (strictly, because we are monitoring current, the faster
rate ka2 must also encompass the, even faster, channel open-
ing step). Accordingly, the corresponding CFTR channel states
are cartooned in Figure 5B as dephosphorylated (‘‘D’’), phos-
phorylatable (‘‘P’’), and maximally activated (‘‘M’’). The greatly
magnified current segment inset in Figure 5A shows that indi-
vidual channels occasionally, if rarely, open and close without
having been phosphorylated by PKA; this current of unphos-
phorylated CFTR channels exposed to ATP was previously
noted (Csana´dy et al., 2005a) to amount to 1.2% ± 0.5%
(n = 13) of that after the same channels were maximally phos-
phorylated. Because even spontaneous opening of CFTR
channels is accompanied by NBD dimerization (Miha´lyi et al.,
2016), which in turn requires disengagement of the R domain,
we propose that the rare openings of unphosphorylated chan-
nels in Figure 5A are enabled by comparably infrequent, revers-ible, R domain release events; those same rare releases of
the R domain presumably also underlie the relatively weak
ATPase activity of dephosphorylated CFTR (Figure 5E). This
low ATPase rate and rare channel openings in the absence of
PKA can be explained by the steady-state distribution of the
CFTR population among D, P, and M states (Figure 5B) being
shifted strongly leftward to only D and P states—with the
slow D-to-P transition resulting in low fractional occupancy of
state P, from which the rare ATP-driven gating and ATPase
cycles can arise. In that case, most of the time, engaged
R domains (state D) inhibit NBD dimerization, but occasional
R domain release (to state P) supports a low level of activity.
For occupancy of state P to remain low in the absence of
PKA, spontaneous release of the R domain must be much
slower than its spontaneous redocking. When PKA is present,
relatively rapid phosphorylation of occasionally released R do-
mains temporarily traps them, delaying their return to the inhib-
itory position and slowly accumulating the CFTR population in
state M, hence accounting for the slow sigmoid time course
of activation of channel current (Figures 5A and 5C). Dephos-
phorylation of the trapped R domains by phosphatases (transi-
tion M-to-P) allows them to spontaneously redock in the chan-
nel vestibule (transition P-to-D). These spontaneous motions of
the R domain likely contribute to its evident disorder observed
in the cryo-EM reconstruction (Figure 1).
Correlation between CFTR Channel Gating Cycle and
ATP Hydrolysis Rates
A record from a patch containing a single CFTR channel (Fig-
ure 5C) recapitulates the sequence of events observed for hun-
dreds of channels (Figure 5A): the very low probability of seeing
a CFTR channel open before phosphorylation, and the delay to
the first opening after adding PKA, can both be attributed to
infrequent disengagement of the unphosphorylated R domain
(i.e., transition D-to-P; Figure 5B). Once phosphorylation of
Rdomain serines reaches a steady state, so does channel gating.Cell 169, 85–95, March 23, 2017 89
Figure 5. PKA Phosphorylation Stimulates
CFTR Channel Gating and ATPase Activity
(A) Macroscopic current in an excised patch
containing hundreds of human CFTR channels
exposed to 2 mM MgATP shows only very few
channel openings (amplified in inset at left) before
phosphorylation, but is strongly stimulated along a
sigmoid time course by 300 nM PKA catalytic
subunit. The red line is a fit to the two-step acti-
vation scheme in (B) yielding the slower, ka1, and
faster, ka2, rates indicated. PKA withdrawal allows
endogenous phosphatases to partially dephos-
phorylate channels, diminishing the current in ATP.
(B) Cartoon model of two-step activation process
of dephosphorylated (‘‘D’’) channels. Infrequent,
reversible, disengagement of the R domain (red
tongue) from its inhibitory position slowly (with rate
ka1) renders channels phosphorylatable (‘‘P’’).
Relatively rapid (rate ka2) phosphorylation by PKA
(indicated by red P on tongue) temporarily traps
the R domain in a permissive position, rendering
the channels maximally activated (‘‘M’’) and al-
lowing maximal channel gating via the cycle in (D).
TMDs, gray; NBD1, blue; NBD2, green; R domain,
red; ATP, yellow. Although steps D-to-P and
P-to-M are both presumed reversible (the former
spontaneously, the latter by phosphatase-medi-
ated dephosphorylation), fitting the activation time
course (in A) with the depicted two-parameter
scheme estimates ‘‘net’’ rates of channel pro-
gression through the sequence of states D-P-M.
(C) Single-channel current recording with addition
of 2 mM MgATP and 300 nM PKA as indicated.
The thin gray bar beneath the record indicates the
segment near the end of the exposure to PKA,
magnified below, with green bars marking times,
tib, the channel spent in the interburst closed state
(‘‘C’’ in D), and red bars marking times, tb, spent in
open burst states (‘‘O1’’ and ‘‘O2’’ in D).
(D) Cartoon representation of gating cycle of fully
phosphorylated CFTR channel. ATP-bound closed
channels (state C) open, with rate kCO = 1/tib, to a
prehydrolytic open state (O1), permitting flow of
chloride ions (purpledots).ATP issplit toADP(orange)
andPi at competent catalytic site 2 (rate k1), leading to
dimerdisruption (rate k2) that causes channel closure.
The open burst duration, tb, comprises time spent
sequentially in both O1 and O2 states.
(E) ATPase rate at 28C of purified human CFTR as
a function of ATP concentration after PKA phos-
phorylation (filled circles) or after dephosphoryla-
tion with lambda phosphatase (empty squares).
The curves show Michaelis-Menten fits, yielding
for phosphorylated CFTR, Km = 187 ± 24 mM,
Vmax = 134 ± 4 nmol/mg/min and for dephos-
phorylated CFTR, Km = 138 ± 30 mM, Vmax = 23 ±
1 nmol/mg/min.
See also Figure S4 and Table S2.In the latter cyclic process, two ATPs are bound in the closed-
channel state, C (Figure 5D; equivalent to state M in Figure 5B)
then sandwiched at the NBD dimer interface, so signaling the
channel gate to open (state O1) until the ATP at the competent,
consensus, site is hydrolyzed (state O2), which leads to dimer
disruption, nucleotide exchange, and channel closure (state C).90 Cell 169, 85–95, March 23, 2017A 20-s segment of the record (gray bar, Figure 5C) is shown
magnified, with individual closed periods and open bursts
marked. Each green bar measures time the channel spent in
closed state C (interburst duration, tib), and each red bar mea-
sures time spent in an open burst, in state O1 and then
O2 (open burst duration, tb). Because >95% of all human
Figure 6. Sequence Conservation Analysis
(A) Sequence conservation analysis of 11 CFTR orthologs. The pairwise sequence identity of human CFTR and its orthologs are: human (100%), pig (92%), rabbit
(92%), ferret (92%), sheep (91%), chicken (80%), mouse (78%), Xenopus (77%), shark (71%), killifish (58%), and zebrafish (55%). The locations of the 53 missense
cystic fibrosis-causing mutations are indicated by yellow spheres.
(B) Sequence conservation of the 12 human ABCC proteins mapped onto the structure of CFTR. The R825–843 segment is omitted as it is only found in CFTR.CFTR channel openings are terminated by hydrolysis of a sin-
gle ATP (Csana´dy et al., 2010), on average the time for comple-
tion of the gating cycle, i.e., tib + tb, which was 1.91 ± 0.5 s for
nine fully phosphorylated CFTR channels (including the one in
Figure 5C) must be identical to that for completion of the
ATPase cycle. In other words, the mean gating cycle rate,
1/(tib + tb), 0.52 s1 for these channels in saturating ATP, at
25C, should match the maximal ATPase turnover rate deter-
mined under comparable conditions. ATPase rates of dephos-
phorylated and fully phosphorylated (Figure S4) purified human
CFTR over a range of ATP concentrations at 28C reveal strong
activation (6-fold) by PKA (Figure 5E), as similarly observed
for purified zebrafish CFTR (Zhang and Chen, 2016). The
maximum ATPase rate of phosphorylated human CFTR,
134 nmol/mg/min (Figure 5E), corresponds to a maximal cycle
turnover rate of 0.37 s1, assuming that 100% of the purified
protein is active in detergent. Given the variability of estimates
of human CFTR channel gating cycle rates in 300–550 nM PKA,
2–5 mM ATP, at 21C–26C (0.47 s1 [Csana´dy et al., 2000],
0.45 s1 [Vergani et al., 2003], 0.53 s1 [Csana´dy et al.,
2005a], 0.72 s1 [Csana´dy et al., 2005b], 0.62 s1 [Csana´dyet al., 2010]), we can conclude that up to 84% of the purified
human protein retains full activity.
CFTR Compared to Other ABCC Transporters
The ABC transporter family includes thousands of proteins found
in all living species, out of which only CFTR is known to function
as an ion channel. Almost all other ABC transporters are active
pumps that translocate substrates against their electrochemical
gradients (Theodoulou and Kerr, 2015). We ask if there are any
special structural features that render CFTR a channel instead
of a pump.
First, we analyzed sequence conservation among 11 function-
ally characterized CFTR orthologs (Aleksandrov et al., 2012;
Cai et al., 2015; Clarke et al., 1992; Kopelman et al., 1995;
Marshall et al., 1991; Price et al., 1996; Riordan et al., 1989;
Rogers et al., 2008; Singer et al., 1998; Sun et al., 2010; Zhang
andChen, 2016). Thepairwise sequence identity betweenhuman
CFTR and each ortholog used in this analysis varies from 55%
(zebrafish) to 92% (pig). Highly conserved residues are found
throughout the pore, the cytosolic extensions of the TM helices,
and the NBDs (Figure 6A). The degree of sequence conservationCell 169, 85–95, March 23, 2017 91
Figure 7. Structural Comparison of CFTR
and MRP1
Human CFTR (hCFTR) is shown in blue and bovine
MRP1 (bMRP1, PDB: 5UJA) in yellow. Because
bMRP1 contains an additional TMD0 domain (not
shown), helices are numbered based on the CFTR
structure.
(A) Superimposition of half1, which comprises the
lasso motif, 6 TM helices, and NBD1.
(B) Superimposition of the other half. Also shown is
a zoom-in view of TM7 and TM8.
(C) The 12 TM helices viewed from the extracellular
side of the membrane. TM7 and TM8 are shown in
cylinder and other helices in ribbon.correlates well with the mutations that cause cystic fibrosis
(https://cftr2.org). Thus, the majority of the 53 missense muta-
tions (Figure 6A, yellow spheres) occur within highly conserved
positions, underscoring the importance of these regions in main-
taining the structural and functional integrity of CFTR.
Next, we extended this analysis to the ABCC subfamily, which
includes members that are closely related in sequence but
diverse in function. In addition to CFTR, the ABCC subfamily
includes nine multidrug-resistance proteins (MRP1-9) that are
ATP-driven efflux pumps and two sulfonylurea receptors
(SUR1 and SUR2) with no known transport substrates (Vasiliou
et al., 2009). The SUR proteins regulate the activity of potassium
channels in the context of complexes known as KATP channels
(Inagaki et al., 1996; Martin et al., 2017). When mapped onto
the structure of CFTR, conserved residues in this subfamily are
mainly found in the cytosolic region of the protein, such as the
NBD catalytic cores, the surfaces of the intracellular vestibule,
and the NBD/TMD interfaces (Figure 6B). Sequences in the TM
region are highly variable, consistent with the distinct functions
of CFTR, MRP, and SUR. These results also suggest that ATP92 Cell 169, 85–95, March 23, 2017binding to the different ABCC proteins
would induce a similar dimerization of
the NBDs and coming together of the
intracellular extensions of the TMDs to
create interactions like those depicted in
Figure 4B.
To understand the structural differ-
ences between a channel and pump in
the same ABCC subfamily, we directly
compared the structures of CFTR and
MRP1 (Johnson and Chen, 2017) (PDB:
5UJA). One half of CFTR, comprising the
lasso motif, TM helices 1, 2, 3, 6, 10, 11,
and NBD1, superimposes very well with
the corresponding regions of MRP1 (Fig-
ure 7A). The structure of the other half of
CFTR is also similar to that of MRP1,
except for TM helices 7 and 8 (Figure 7B).
In MRP1 both TM7 and TM8 are con-
tinuous helices, typical of other ABC
transporters. In CFTR, however, TM8
breaks into three short helices and TM7
is displaced from its usual position(Figures 7B and 7C). A mutation within the helical break,
L927P, causes cystic fibrosis, possibly by altering the flexibility
of TM8. Helical breaks inside the low dielectric core of the mem-
brane can create potential ion binding sites (Doyle et al., 1998;
Dutzler et al., 2002) and flexible hinges to facilitate gating. As
TM8 lines the pore, it could play a critical role in ion conduction
and gating. This unique feature of CFTR is likely the structural
basis for its channel function.
In summary, we presented here the cryo-EM structure
of human CFTR determined in the dephosphorylated, ATP-
free conformation. The structure was analyzed to further estab-
lish the architecture of the ion pore, the functions of many
positively charged residues, and to identify the structural
basis for CFTR’s channel activity. We showed how the
observed location of the R domain informs understanding of
CFTR’s slow activation by phosphorylation, as well as of
infrequent cycling by unphosphorylated CFTR. We also
analyzed the relationship between ATP hydrolysis and channel
gating, illuminating how these two events correlate in a CFTR
duty cycle.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture
Insect cells were cultured in sf-900 II SFM medium (GIBCO) supplemented with 5% FBS and 1% Anti-Anti. Freestyle 293 (GIBCO)
supplemented with 2% FBS and 1% Anti-Anti was used for mammalian cells. Insect cells were maintained at 28C and mammalian
cells were maintained at 37C with 8% CO2 and 80% humidity.
Isolation and injection of Xenopus laevis oocytes
Xenopus laevis oocytes were removed from anesthesized frogs by ovarian dissection following a IACUC-approved protocol, and the
follicular layer removed by collagenase treatment. Oocytes injectedwith cRNAwere incubated at 18C in amodified Ringer’s solution
supplemented with 1.8 mM CaCl2 and 50 mg/ml gentamycin.
METHOD DETAILS
Expression and Purification of Protein
HumanCFTRwas expressed and purifiedwith a process similar to that described for zebrafishCFTR (Zhang andChen, 2016). Briefly,
human CFTR gene with a C-terminal GFP tag was cloned into a BacMam expression vector. Human CFTR protein was expressed inCell 169, 85–95.e1–e4, March 23, 2017 e2
HEK293S GnTI- cells after baculovirus transduction (Goehring et al., 2014). To purify the protein, cells were first solubilized in lysis
buffer (20 mM Tris-HCl pH 7.5, 2 mM MgCl2, 200 mM NaCl, 20% glycerol, and 2 mM DTT) with detergent (1% 2,2-didecylpro-
pane-1,3-bis-b-D-maltopyranoside (LMNG), 0.2% cholesteryl hemisuccinate (CHS), protease inhibitors (1 mg/ml Leupeptin,
1 mg/ml Pepstatin, 1 mg/ml Aprotonin, 100 mg/ml Trypsin inhibitor, 1 mM Benzamidine, and 1 mM PMSF), and DNase I (3 mg/ml)
for 2 hr at 4C. The supernatant was collected after centrifugation at 75,000 g for 1 hr. GFP nanobody (GFPnb) coupled CNBR-acti-
vated Sepharose beads (GE Healthcare) were used to affinity purify the protein. GFPnb beads were washed with buffer A (20 mM
Tris-HCl pH 7.5, 200 mM NaCl, 2 mM DTT, 2 mMMgCl2, and 0.06% digitonin). The protein was eluted with buffer A after incubation
with PreScission protease (10:1 w/w ratio) overnight and was further purified by size exclusion chromatography using a Superose 6
10/300 column (GE Healthcare).
ATPase Activity Assay
The ATPase activity was measured using an ATP regeneration-NADH consumption coupled system (Scharschmidt et al., 1979).
Pyruvate kinase (PK), lactate dehydrogenase (LDH), NADH, and phosphoenolpyruvate (PEP) were purchased from Roche. Purified
CFTR was treated with lambda PP (NEB) or PKA (NEB) for 1 hr followed by gel filtration to remove excess ATP and enzyme. The re-
action was carried out in a reaction buffer (50 mMHEPES pH 8.0, 150 mM KCl, 0.06% digitonin, 2 mMDTT, 2 mMMgCl2) containing
60 mg/ml of PK, 32 mg/ml LDH, 4 mMPEP, and 0.15mMNADH. Because of the light sensitivity of NADH, the reaction buffer was kept
in the dark before the assay was initiated. Reaction was carried out in 30 ml aliquots in triplicate with a final CFTR concentration of
0.2 mMand different concentrations of MgCl2/ATP. NADH fluorescence depletion was recorded continuously for 45min by an Infinite
M1000 Microplate Reader (TECAN) with excitation wavelength of 340 nm and emission wavelength of 445 nm.
Electrophysiology
Human CFTR cDNA (pGEMHE-CFTR) was transcribed in vitro using T7 polymerase (Ambion, mMessage T7), and 0.1-10 ng cRNA
were injected into Xenopus laevis oocytes. Current recordings were made at 25C in inside-out patches excised from the oocytes
1-3 days after injection.
Patch pipette solution contained (in mM): 136 NMDG-Cl, 2 MgCl2, 5 HEPES, pH 7.4 with NMDG. The continuously flowing bath
solution could be exchanged with a time constant < 100 ms, and contained (in mM): 134 NMDG-Cl, 2 MgCl2, 5 HEPES, 0.5
EGTA, pH 7.1 with NMDG. MgATP (2 mM) was added from a 400-mM aqueous stock solution (pH 7.1 with NMDG). 300 nM catalytic
subunit of PKA (Sigma) was applied to activate CFTR channels. Macroscopic and unitary currents were recorded at a membrane
potential of 80 mV (Axopatch 200B, Molecular devices), filtered at 2 kHz, and digitized at 10 kHz.
Single-channel patches were identified from long (typically 10 min) recordings without superimposed channel openings. To recon-
struct open bursts and interbursts, of durations tb and tib respectively, currents from patches containing no superimposed channel
openings were baseline subtracted to remove slow drifts, refiltered at 100 Hz, and idealized by half-amplitude threshold crossing.
After imposition of a fixed dead time of 4 ms, the resulting events lists were subjected to kinetic analysis as described (Csana´dy
et al., 2000). Open bursts were isolated by suppressing brief closures shorter than a cutoff estimated using the method of Magleby
and Pallotta (Magleby and Pallotta, 1983), as described (Csana´dy et al., 2010).
Macroscopic current activation time courses were fit to a two-step two-parameter activation scheme, D- > P- >M, using non-linear
least-squares methods (pCLAMP 9, Molecular Devices), yielding net sequential activation rates, ka1 and ka2 (Figure 5B).
EM Sample Preparation and Data collection
The purified human CFTR sample was concentrated to 5.5 mg/ml and supplemented with 3 mM fluorinated Fos-Choline-8. Three ml
of the protein sample was applied to each Quantifoil R1.2/1.3 400 mesh Au holey carbon grid (Quantifoil), blotted with Vitrobot Mark
IV (FEI) for 3 s at blot force 0 after 15 s wait time, and frozen in liquid ethane. A 300 kV Titan Krios (FEI) with a Gatan K2 Summit direct
electron detector (Gatan) was used to image the grids. Images were recorded by Serial EM in super-resolution mode with a pixel size
of 0.4085 A˚/pixel. For data collection, each image was exposed for 7 s in 50 subframes with a dose rate of 8 electrons per pixel per
second. A defocus range from 0.8 mm to 2.5 mm was used.
Imaging Processing and 3D reconstruction
Dark subtracted images were first normalized by gain reference and binned by 2x, resulting in a pixel size of 0.817 A˚/pixel. Drift
correction was performed using the program Unblur (Grant and Grigorieff, 2015). The contrast transfer function (CTF) was estimated
using CTFFIND4 (Rohou and Grigorieff, 2015). To generate templates for automatic picking, around 5000 particles were manually
picked and classified by 2D classification in RELION (Scheres, 2012). After automatic picking and manual micrograph inspection,
415,915 particles were extracted for subsequent 2D and 3D classification. Motion correction of individual particles was performed
using the program alignparts_lmbfgs (Rubinstein and Brubaker, 2015). Using the structure of zebrafish CFTR (PDB: 5UAR) low pass
filtered to 60 A˚ as the initial model, 3D classification was carried out in RELION (Scheres, 2012). The best class, containing 33%of the
particles, gave rise to an 8.26 A˚ map. The refinement was performed in FREALIGN (Grigorieff, 2016) using this best class as the initial
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Model Construction
To get better side chain densities for model building, we sharpened one half-map using BFACTOR.EXE (author: Nikolaus Grigorieff)
with a resolution limit of 3.9 A˚ and a b-factor value of 250 A˚2. To build TMD1 and TMD2 (residues 5-389 and 844-1172), we first
generated a model based on the structure of zebrafish CFTR (PDB: 5UAR) using the program Modeler (Webb and Sali, 2014),
then fitted and rebuilt the model into the cryo-EM map in COOT (Emsley et al., 2010). For the NBDs, the crystal structures of human
NBD1 (PDB: 2PZG) and human NBD2 (PDB: 3GD7) were used as initial models. For regions with good densities, the residues were
adjusted based on themap. For regions with weak densities, the residues were kept as they were in themodels. The overall densities
for the R domain were too weak to build; however, the C-terminal region of the R domain, which connects to elbow helix 2 of TMD2,
had continuous densities. Based on the secondary structure prediction by Phyre2 (Kelley et al., 2015), this region contains an a-helix
(residues 830-841). Therefore, wemodeled a poly-alanine helix into the tubular density. The final structure includes residues 5-389 of
TMD1; 390-402 and 439-645 of NBD1; 844-883 and 909-1172 of TMD2; 1207-1436 of NBD2; and 19 alanines that likely correspond
to residues 825-843 of the R domain.
Model Refinement and Validation
Themodel was refined in real space using PHENIX (Adams et al., 2010) and also in reciprocal space using Refmac (Brown et al., 2015;
Murshudov et al., 1997). Structural factors were calculated from a half-map (working) using the program Sfall (Ten Eyck, 1977). The
R work and R free values were calculated with a mask containing the model plus a 2A˚ margin. Fourier shell correlations (FSCs) were
calculated between the two half maps, the model against the working map, the other (free) half map, and full (sum) map (Scheres and
Chen, 2012;Wang et al., 2014). Local resolutions were estimated using Blocres (Heymann andBelnap, 2007). MolProbity (Chen et al.,
2010; Davis et al., 2007) was used to validate the geometries of the model.
Structure figures were genereated using Pymol (http://www.pymol.org), Chimera (Pettersen et al., 2004), and HOLE (Smart
et al., 1996).
Sequence conservation analysis
Sequence alignments were carried out in ClustalX (Larkin et al., 2007) and the conservation analysis was performed using the
ConSurf Server (Ashkenazy et al., 2016).
QUANTIFICATION AND STATISTICAL ANALYSIS
GraphPad Prism 6 was used to fit the Michaelis-Menten curve of ATPase activity and to calculate Km and Vmax. The goodness of fit
was represented by R square values (phosphorylated protein has an R square of 0.95 and dephosphorylated protein has an R square
of 0.84).
All electrophysiological kinetic parameters are given as mean ± SEM extracted from n = 9 and 11 recordings, respectively, of
single-channel and macroscopic currents.
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the structure reported in this paper are PDB: 5UAK and EMD: EMD-8516.Cell 169, 85–95.e1–e4, March 23, 2017 e4
Supplemental Figures
Figure S1. Cryo-EM Analysis, Related to Figure 1
(A) A representative micrograph at defocus of 2.3 mm.
(B) Representative 2D class averages, output of Relion (Scheres, 2012).
(C) The overall EM map colored by local resolution estimation using Blocres (Heymann and Belnap, 2007).
(D) Fourier Shell Correlation (FSC) as a function of resolution, using Frealign (Grigorieff, 2016) output.
(E) FSC calculated between the refined structure and three different maps. Black: the map calculated using the full dataset (sum); Red: the half map used in
refinement (work); Blue: the other half map (free).
Figure S2. EM Density of Different Parts of the Structure, Related to Figure 1
Figure S3. The Cryo-EM Map of CFTR without B-Factor Sharpening, Related to Figures 1 and 4
Figure S4. Analysis of the Phosphorylation State of Purified CFTR, Related to Figure 5
Untreated, PKA-treated, and LambdaProtein Phosphatase (PP)-treated samples on SDS-PAGEwere stained byCoomassie blue (upper) and the Pro-QDiamond
Phosphoprotein Gel Stain (lower).
